Vaxcell-Bio Therapeutics Revenue

In the year 2024, Vaxcell-Bio Therapeutics had annual revenue of 1.90B KRW with 13,737.28% growth. Vaxcell-Bio Therapeutics had revenue of 921.53M in the quarter ending December 31, 2024, with 6,615.06% growth.

Revenue

1.90B

Revenue Growth

+13,737.28%

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

n/a

Market Cap

182.11B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.90B	1.89B	13,737.28%
Dec 31, 2023	13.72M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
iNtRON Biotechnology	5.56B
Macrogen	179.98B
ENCell	5.91B
Genexine	5.81B
EASY BIO,Inc.	465.24B
HLB Therapeutics	63.25B
Helixmith	3.74B
JETEMA,	75.55B

Revenue Rankings